Modulation of Tumor Growth and Tumor Induced Angiogenesis After Epidermal Growth Factor Receptor Inhibition by ZD1839 in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Modulation of Tumor Growth and Tumor Induced Angiogenesis After Epidermal Growth Factor Receptor Inhibition by ZD1839 in Renal Cell Carcinoma

Published:2004-02 Issue:2 Volume:171 Page:897-902
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

ASAKUMA JUNICHI¹,SUMITOMO MAKOTO¹,ASANO TAKAKO¹,ASANO TOMOHIKO¹,HAYAKAWA MASAMICHI¹

Affiliation:

1. From the Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival;Brabender;Clin Cancer Res,2001

2. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival;Grandis;J Natl Cancer Inst,1998

3. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features;Gasparini;J Clin Oncol,1992

4. Epidermal growth factor receptor dependence in human tumors: more than just expression?;Arteaga;Oncologist,2002

5. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor;Ciardiello;Clin Cancer Res,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gefitinib modulates stress fibers and tubular-like structure formation and attenuates angiogenesis in an in vivo chicken model of chorioallantoic membrane angiogenesis;Biochemical and Biophysical Research Communications;2020-06

2. Treatment for Non-clear Cell Renal Cell Carcinoma;Renal Cell Carcinoma;2017

3. Prognostic impact of epidermal growth factor receptor on clear cell renal cell carcinoma: Does it change with different expression patterns;INDIAN J PATHOL MICR;2016

4. Lapatinib and renal cell carcinoma;Expert Opinion on Investigational Drugs;2012-08-09

5. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway;Oncology Reports;2012-06-19